You are here

John Johnson

John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?

Endpoints

Thu, 12/20/18 - 12:20 am

Melinta Therapeutics

Dendreon's CEO Exits: Is this the Beginning of the End?

Motley Fool

Tue, 06/10/14 - 04:42 pm

Dendreon shareholders gang up on CEO at annual meeting

Fierce Pharma

Thu, 06/14/12 - 01:18 pm

New CEO = Dendreon Takeover Target?

Motley Fool

Thu, 02/2/12 - 10:09 am

Savient Names Lilly’s John Johnson Chief Executive

Bloomberg

Tue, 01/25/11 - 10:46 am